2don MSN
AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...
AstraZeneca PLC shed £15 billion in market capitalization on Tuesday, after investors were underwhelmed by early data from a ...
American Woman on MSN3d
FitSpresso Reviews: Is This Weight Loss Pill Good? Latest Ingredients Research, Consumer Complaints, Side Effects Report!Fitspresso is a dietary supplement that is made using organic ingredients to boost the natural ability of the body to ...
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
Hosted on MSN6d
A new weight loss pill outperformed Novo Nordisk's versionViking Therapeutics (VKTX) released new clinical trial data on Sunday for its experimental weight-loss drugs, which include a ...
Viking Therapeutics shares surge as VK2735 shows significant weight loss in early-stage study, with plans for a phase 2 study ...
MarketWatch on MSN9d
Hoping for a weight-loss pill? It could get closer to reality next week.Viking Therapeutics Inc.’s stock was up up as much as 3.8% early Friday as excitement continued to build about data on the ...
Pfizer (PFE) offered up some more details on its weight loss drug pipeline on Tuesday during a call with investors after it ...
Viking Therapeutics (VKTX) released new clinical trial data on Sunday for its experimental weight-loss drugs, which include a highly anticipated oral pill. The San Diego-based company’s stock ...
Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback